KW-6002 to Treat Parkinson's Disease

NCT00006337 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

NIH

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: KW-6002
DRUG: IV Levodopa

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)